- Home
- HCM vs OCUL Comparison
HCM vs OCUL Comparison
Compare HCM & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCM
- OCUL
- Stock Information
- Founded
- HCM 2000
- OCUL 2006
- Country
- HCM Hong Kong
- OCUL United States
- Employees
- HCM N/A
- OCUL N/A
- Industry
- HCM Biotechnology: Pharmaceutical Preparations
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- HCM Health Care
- OCUL Health Care
- Exchange
- HCM Nasdaq
- OCUL Nasdaq
- Market Cap
- HCM 2.6B
- OCUL 2.3B
- IPO Year
- HCM N/A
- OCUL 2014
- Fundamental
- Price
- HCM $16.01
- OCUL $11.26
- Analyst Decision
- HCM Sell
- OCUL Strong Buy
- Analyst Count
- HCM 1
- OCUL 9
- Target Price
- HCM $13.75
- OCUL $22.13
- AVG Volume (30 Days)
- HCM 56.9K
- OCUL 3.2M
- Earning Date
- HCM 08-07-2025
- OCUL 11-13-2025
- Dividend Yield
- HCM N/A
- OCUL N/A
- EPS Growth
- HCM N/A
- OCUL N/A
- EPS
- HCM 0.53
- OCUL N/A
- Revenue
- HCM $602,197,000.00
- OCUL $56,664,000.00
- Revenue This Year
- HCM N/A
- OCUL N/A
- Revenue Next Year
- HCM $15.49
- OCUL $18.87
- P/E Ratio
- HCM $5.91
- OCUL N/A
- Revenue Growth
- HCM N/A
- OCUL N/A
- 52 Week Low
- HCM $11.51
- OCUL $5.79
- 52 Week High
- HCM $21.50
- OCUL $13.85
- Technical
- Relative Strength Index (RSI)
- HCM 48.16
- OCUL 41.98
- Support Level
- HCM $17.19
- OCUL $10.85
- Resistance Level
- HCM $16.35
- OCUL $11.77
- Average True Range (ATR)
- HCM 0.29
- OCUL 0.72
- MACD
- HCM -0.01
- OCUL -0.16
- Stochastic Oscillator
- HCM 21.74
- OCUL 28.63
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.